Watala C - Search Results

1

Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions.

Boncler M, Rywaniak J, Sicinska P, Watala C. Boncler M, et al. Among authors: watala c. Blood Coagul Fibrinolysis. 2011 Jun;22(4):301-9. doi: 10.1097/MBC.0b013e3283451308. Blood Coagul Fibrinolysis. 2011. PMID: 21372690

2

Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.

Watala C, Gwoździński K, Pluskota E, Pietrucha T, Walkowiak B, Trojanowski Z, Cierniewski CS. Watala C, et al. Thromb Haemost. 1996 Jan;75(1):147-53. Thromb Haemost. 1996. PMID: 8713794

3

Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus.

Watala C, Boncler M, Golański J, Koziołkiewcz W, Trojanowski Z, Walkowiak B. Watala C, et al. Eur J Haematol. 1998 Nov;61(5):319-26. doi: 10.1111/j.1600-0609.1998.tb01095.x. Eur J Haematol. 1998. PMID: 9855247

4

Release of calcium and P-selectin from intraplatelet granules is hampered by procaine.

Watala C, Boncler M, Golański J, Koziołkiewicz W, Walkowiak B, Cierniewski CS. Watala C, et al. Thromb Res. 1999 Apr 1;94(1):1-11. doi: 10.1016/s0049-3848(98)00174-1. Thromb Res. 1999. PMID: 10213176

5

[The significance of thrombomodulin in regulation of coagulation and fibrinolysis].

Boncler M, Watała C. Boncler M, et al. Among authors: watala c. Postepy Biochem. 1999;45(4):285-92. Postepy Biochem. 1999. PMID: 10786372 Review. Polish. No abstract available.

6

Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: their relevance to palliative systemic-pulmonary shunt.

Kierzkowska B, Stańczyk J, Wiectawska B, Rózalski M, Boncler M, Chrul S, Watala C. Kierzkowska B, et al. Among authors: watala c. Int J Cardiol. 2001 Jun;79(1):49-59. doi: 10.1016/s0167-5273(01)00404-1. Int J Cardiol. 2001. PMID: 11399341

7

Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report.

Golanski J, Golanski R, Chizynski K, Iwaszkiewicz A, Rozalski M, Wieclawska B, Boncler M, Watala C. Golanski J, et al. Among authors: watala c. Platelets. 2001 Jun;12(4):241-7. doi: 10.1080/09537100120058700. Platelets. 2001. PMID: 11454259 Free article.

8

Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin.

Boncler MA, Koziolkiewicz M, Watala C. Boncler MA, et al. Among authors: watala c. Thromb Res. 2001 Nov 1;104(3):215-22. doi: 10.1016/s0049-3848(01)00357-7. Thromb Res. 2001. PMID: 11672764

9

Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation.

Rozalski M, Boncler M, Golanski J, Watala C. Rozalski M, et al. Among authors: watala c. Biochem Pharmacol. 2001 Nov 15;62(10):1399-408. doi: 10.1016/s0006-2952(01)00777-8. Biochem Pharmacol. 2001. PMID: 11709200

10

Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.

Boncler MA, Golanski J, Paczuski R, Watala C. Boncler MA, et al. Among authors: watala c. J Mol Med (Berl). 2002 Dec;80(12):796-801. doi: 10.1007/s00109-002-0386-7. Epub 2002 Nov 22. J Mol Med (Berl). 2002. PMID: 12483465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters